Skip to Main Content

Author Details

Mila B Ortigoza
NYU Grossman School of Medicine
2006
18
9
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36238716A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8.bioRxiv2023
37866115Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study.EBioMedicine2023
37230979A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8.Nat Commun2023
37398388Targeting host sialic acids in the upper respiratory tract with a broadly-acting neuraminidase to inhibit influenza virus transmission.bioRxiv2023
36844451Delta-Omicron recombinant escapes therapeutic antibody neutralization.iScience2023
36415470Inflammation durably imprints memory CD4+ T cells.bioRxiv2023
35076699Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis.JAMA Netw Open2022
35411351Delta-Omicron recombinant escapes therapeutic antibody neutralization.bioRxiv2022
34901997Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.JAMA Intern Med2022
35076698Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.JAMA Netw Open2022
33819312Neuraminidase B controls neuraminidase A-dependent mucus production and evasion.PLoS Pathog2021
33593970Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.mBio2021
30563897An Infant Mouse Model of Influenza Virus Transmission Demonstrates the Role of Virus-Specific Shedding, Humoral Immunity, and Sialidase Expression by Colonizing Streptococcus pneumoniae.mBio2018
22577360A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.PLoS Pathog2012
23145065Identification of small molecules with type I interferon inducing properties by high-throughput screening.PLoS One2012
20027183Human host factors required for influenza virus replication.Nature2010
19349871The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.J Acquir Immune Defic Syndr2009
16873254Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice.J Virol2006
  • 1 - 18 of 18

Recommended Authors

Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 5
Sarah R Leist
University of North Carolina at Chapel Hill
Career Start Year 2014
Number of shared co-authors 3
Soner Yildiz
University of Geneva
Career Start Year 2014
Number of shared co-authors 3
Brook E Heaton
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Marie O Pohl
Institute of Medical Virology, University of Zurich
Career Start Year 2012
Number of shared co-authors 8
Anshu P Gounder
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2012
Number of shared co-authors 7
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 12
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 5
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 5
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 3
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 6
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 1
Amber M Smith
University of California san francisco
Career Start Year 2006
Number of shared co-authors 3
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2006
Number of shared co-authors 0
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 3
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 1
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 4
Lisa E Gralinski
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 1
Balaji Manicassamy
University of Iowa
Career Start Year 2002
Number of shared co-authors 11
Man-Seong Park
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 5
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 14
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 9
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
James D Chappell
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 1
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 4
Terrence M Tumpey
Centers for Disease Control and Prevention.
Career Start Year 1989
Number of shared co-authors 5
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 4
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Career Start Year 1979
Number of shared co-authors 3
James E Crowe
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 2

Collaborators

Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Mengling Liu
NYU Grossman School of Medicine
Co-authored papers 3
Megan L Shaw
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Liise-Anne Pirofski
Albert Einstein College of Medicine, Montefiore Medical Center
Co-authored papers 3
Elliott M Antman
Co-authored papers 2
Juan Ayllon
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 2
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Geert Meyfroidt
University Hospitals Leuven and KU Leuven
Co-authored papers 2
David N Hager
Johns Hopkins University
Co-authored papers 1
Nicole Verdun
Center for Biologics Evaluation and Research
Co-authored papers 1
Silke Stertz
Institute of Medical Virology, University of Zurich
Co-authored papers 1
Sourav Bandyopadhyay
University of California San Francisco
Co-authored papers 1
Ghislain M C Bonamy
Prestige BioPharma Ltd
Co-authored papers 1
Buu Tu
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Co-authored papers 1
Qinshan Gao
Merck & Co., Inc.
Co-authored papers 1
Dushyantha Jayaweera
University of Miami, Miller School of Medicine
Co-authored papers 1
Jessica L Jacobson
Co-authored papers 1
John A T Young
Roche Pharma
Co-authored papers 1
Jeanne E Hendrickson
Center for Transfusion and Cellular Therapy, Emory University School of Medicine
Co-authored papers 1
Yingyao Zhou
Genomics Institute of the Novartis Research Foundation
Co-authored papers 1
Mark J Mulligan
Co-authored papers 1
Shane E Andrews
Co-authored papers 1
Christopher A Tormey
Yale University School of Medicine, Yale-New Haven Hospital
Co-authored papers 1
Judith G Alamares
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Anthony P Orth
Genomics Institute of the Novartis Research Foundation
Co-authored papers 1
Hans-Heinrich Hoffmann
The Rockefeller University
Co-authored papers 1
Donna M Tscherne
Mount Sinai School of Medicine
Co-authored papers 1
Yuhong Liang
Emory University
Co-authored papers 1
Suchita Bhattacharyya
Feinberg School of Medicine, Northwestern University
Co-authored papers 1
Release 1.2